Approval · Notice of Compliance 4779 · 2004
EXTRANEAL: Notice of Compliance 4779
Issued June 30, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4779
- Date
- June 30, 2004
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change for test on finished product
- Therapeutic class
- Peritoneal dialysis solution
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXTRANEAL | 02240806 | Marketed |
Medicinal ingredients
- CALCIUM CHLORIDE 257 MG per L
- MAGNESIUM CHLORIDE 51 MG per L
- SODIUM CHLORIDE 5.4 G per L
- SODIUM LACTATE 4.5 G per L
- ICODEXTRIN 75 G per L